$174 Billion by 2035; Is Drug Discovery Entering Its Smartest Era Yet?

Reinventing the Science of Discovery AI Is Redefining the Drug Development Equation Why R&D Spending Continues to Surge Small Molecules Still Dominate—but Biologics Surge Ahead Oncology Leads—but Neurology Gains Ground Technology Platforms That Drive Discovery CROs, CDMOs, and the Rise of Outsourced Innovation North America Dominates—Asia-Pacific Accelerates From Bench to Bedside: The Value Chain in Motion Collaboration as Competitive Strategy The Personalized Medicine Imperative The Challenges That Persist Looking Ahead: A Smarter, Faster, More Connected Future